Atlas Venture Life Science Advisors’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $18.9M | Hold |
|
|||||
|
2024
Q1 | $17.1M | Hold |
|
|||||
|
2023
Q4 | $17.7M | Hold |
|
|||||
|
2023
Q3 | $35.9M | Hold |
|
|||||
|
2023
Q2 | $48.7M | Hold |
|
|||||
|
2023
Q1 | $37.1M | Hold |
|
|||||
|
2022
Q4 | $57.1M | Sell |
|
|||||
|
2022
Q3 | $53.7M | Sell |
|
|||||
|
2022
Q2 | $56.1M | Hold |
|
|||||
|
2022
Q1 | $54.5M | Hold |
|
|||||
|
2021
Q4 | $87M | Buy |
|